Literature DB >> 19646559

Multimodality imaging: beyond PET/CT and SPECT/CT.

Simon R Cherry1.   

Abstract

Multimodality imaging with positron emission tomography/computed tomography (PET/CT) and single-photon emission computed tomography (SPECT)/CT has become commonplace in clinical practice and in preclinical and basic biomedical research. Do other combinations of imaging modalities have a similar potential to impact medical science and clinical medicine? Presently, the combination of PET or SPECT with magnetic resonance imaging (MRI) is an area of active research, while other, perhaps less obvious combinations, including CT/MRI and PET/optical also are being studied. In addition to the integration of the instrumentation, there are parallel developments in synthesizing imaging agents that can be viewed by multiple imaging modalities. Is the fusion of PET and SPECT with CT the ultimate answer in multimodality imaging, or is it just the first example of a more general trend toward harnessing the complementary nature of the different modalities on integrated imaging platforms?

Entities:  

Mesh:

Year:  2009        PMID: 19646559      PMCID: PMC2735449          DOI: 10.1053/j.semnuclmed.2009.03.001

Source DB:  PubMed          Journal:  Semin Nucl Med        ISSN: 0001-2998            Impact factor:   4.446


  37 in total

1.  Simultaneous in vivo positron emission tomography and magnetic resonance imaging.

Authors:  Ciprian Catana; Daniel Procissi; Yibao Wu; Martin S Judenhofer; Jinyi Qi; Bernd J Pichler; Russell E Jacobs; Simon R Cherry
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-04       Impact factor: 11.205

2.  Is MR-guided attenuation correction a viable option for dual-modality PET/MR imaging?

Authors:  Habib Zaidi
Journal:  Radiology       Date:  2007-09       Impact factor: 11.105

3.  MRI-based attenuation correction for PET/MRI: a novel approach combining pattern recognition and atlas registration.

Authors:  Matthias Hofmann; Florian Steinke; Verena Scheel; Guillaume Charpiat; Jason Farquhar; Philip Aschoff; Michael Brady; Bernhard Schölkopf; Bernd J Pichler
Journal:  J Nucl Med       Date:  2008-10-16       Impact factor: 10.057

Review 4.  Dual-modality imaging: combining anatomy and function.

Authors:  David W Townsend
Journal:  J Nucl Med       Date:  2008-05-15       Impact factor: 10.057

Review 5.  Positron emission tomography/magnetic resonance imaging: the next generation of multimodality imaging?

Authors:  Bernd J Pichler; Hans F Wehrl; Armin Kolb; Martin S Judenhofer
Journal:  Semin Nucl Med       Date:  2008-05       Impact factor: 4.446

6.  Simultaneous PET-MRI: a new approach for functional and morphological imaging.

Authors:  Martin S Judenhofer; Hans F Wehrl; Danny F Newport; Ciprian Catana; Stefan B Siegel; Markus Becker; Axel Thielscher; Manfred Kneilling; Matthias P Lichy; Martin Eichner; Karin Klingel; Gerald Reischl; Stefan Widmaier; Martin Röcken; Robert E Nutt; Hans-Jürgen Machulla; Kamil Uludag; Simon R Cherry; Claus D Claussen; Bernd J Pichler
Journal:  Nat Med       Date:  2008-03-23       Impact factor: 53.440

Review 7.  Prospects of photoacoustic tomography.

Authors:  Lihong V Wang
Journal:  Med Phys       Date:  2008-12       Impact factor: 4.071

8.  Synthesis of 64Cu-labeled magnetic nanoparticles for multimodal imaging.

Authors:  Benjamin R Jarrett; Björn Gustafsson; David L Kukis; Angelique Y Louie
Journal:  Bioconjug Chem       Date:  2008-06-26       Impact factor: 4.774

9.  Simultaneous MR/PET imaging of the human brain: feasibility study.

Authors:  Heinz-Peter W Schlemmer; Bernd J Pichler; Matthias Schmand; Ziad Burbar; Christian Michel; Ralf Ladebeck; Kirstin Jattke; David Townsend; Claude Nahmias; Pradeep K Jacob; Wolf-Dieter Heiss; Claus D Claussen
Journal:  Radiology       Date:  2008-09       Impact factor: 11.105

10.  Dynamic microPET imaging of ultrasound contrast agents and lipid delivery.

Authors:  Michaelann S Tartis; Dustin E Kruse; Hairong Zheng; Hua Zhang; Azadeh Kheirolomoom; Jan Marik; Katherine W Ferrara
Journal:  J Control Release       Date:  2008-07-29       Impact factor: 9.776

View more
  59 in total

1.  Quantitative, simultaneous PET/MRI for intratumoral imaging with an MRI-compatible PET scanner.

Authors:  Thomas S C Ng; James R Bading; Ryan Park; Hargun Sohi; Daniel Procissi; David Colcher; Peter S Conti; Simon R Cherry; Andrew A Raubitschek; Russell E Jacobs
Journal:  J Nucl Med       Date:  2012-06-01       Impact factor: 10.057

2.  Monitoring response to imatinib using MRI signals in aggressive fibromatosis.

Authors:  Alexander Walter Sauter; Joerg T Hartmann; Marius S Horger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-11-04       Impact factor: 9.236

Review 3.  Cardiovascular molecular imaging: focus on clinical translation.

Authors:  Ian Y Chen; Joseph C Wu
Journal:  Circulation       Date:  2011-02-01       Impact factor: 29.690

4.  FMT-XCT: in vivo animal studies with hybrid fluorescence molecular tomography-X-ray computed tomography.

Authors:  Angelique Ale; Vladimir Ermolayev; Eva Herzog; Christian Cohrs; Martin Hrabé de Angelis; Vasilis Ntziachristos
Journal:  Nat Methods       Date:  2012-05-06       Impact factor: 28.547

Review 5.  Preclinical imaging: an essential ally in modern biosciences.

Authors:  Lídia Cunha; Ildiko Horvath; Sara Ferreira; Joana Lemos; Pedro Costa; Domingos Vieira; Dániel S Veres; Krisztián Szigeti; Teresa Summavielle; Domokos Máthé; Luís F Metello
Journal:  Mol Diagn Ther       Date:  2014-04       Impact factor: 4.074

Review 6.  SPECT and PET in ischemic heart failure.

Authors:  George Angelidis; Gregory Giamouzis; Georgios Karagiannis; Javed Butler; Ioannis Tsougos; Varvara Valotassiou; George Giannakoulas; Nikolaos Dimakopoulos; Andrew Xanthopoulos; John Skoularigis; Filippos Triposkiadis; Panagiotis Georgoulias
Journal:  Heart Fail Rev       Date:  2017-03       Impact factor: 4.214

7.  Radiolabeled oligonucleotides for antisense imaging.

Authors:  Arun K Iyer; Jiang He
Journal:  Curr Org Synth       Date:  2011-08-01       Impact factor: 1.975

8.  (89)Zr-labeled paramagnetic octreotide-liposomes for PET-MR imaging of cancer.

Authors:  Diane S Abou; Daniel L J Thorek; Nicholas N Ramos; Martijn W H Pinkse; Hubert T Wolterbeek; Sean D Carlin; Bradley J Beattie; Jason S Lewis
Journal:  Pharm Res       Date:  2012-12-07       Impact factor: 4.200

Review 9.  Functional imaging for prostate cancer: therapeutic implications.

Authors:  Carina Mari Aparici; Youngho Seo
Journal:  Semin Nucl Med       Date:  2012-09       Impact factor: 4.446

Review 10.  Morphology supporting function: attenuation correction for SPECT/CT, PET/CT, and PET/MR imaging.

Authors:  Tzu C Lee; Adam M Alessio; Robert M Miyaoka; Paul E Kinahan
Journal:  Q J Nucl Med Mol Imaging       Date:  2015-11-17       Impact factor: 2.346

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.